DRUG DELEIVERY TO THE LUNG VOL.162

Enregistré dans:

Détails bibliographiques
Auteur principal:	BISGAARD HANS
Format:	Livre
Publié:	NEW YORK 2002
Sujets:
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

DRUG DELIVERY TO THE LUNG
par: BISGAARD HANS [E], OCALLAGHAN CHRIS [E], SMALDONE GERALD C.
Publié: (2002)

DRUG DELIVERY TO THE LUNG
par: BISGARD HANS
Publié: (2002)

HERBAL SUPPLEMENTS DRUG INTERACTIONS (MD. SERIES 162)
par: LAM Y.W. FRANCIS
Publié: (2006)

RCR ARQUITECTES 2007 2012-162

The End of the Trail (The Hardy Boys #162)
par: Franklin W. Dixon
Publié: (2000)

LOOK AT YOUR BODY LUNGS
par: PARKAR STEVE
Publié: (2001)

KNOWLEDGE ENCYCLOPEDIA HUMAN BODY LUNGS & RESPIRATORY SYSTEM
par: WONDER HOUSE
Publié: (2023)

IMMEDIATE EFFECTS OF CUPPING ON LUNG FUNCTION IN NORMAL HEALTHY INDIVIDUALS
par: MADHURA PRASHANT WORLIKAR
Publié: (2019)

INVESTIGATING THE POTENCY OF SMALL MOLECULES IN LUNG AND EPIDERMAL CANCER CELL LINES
par: Rao Shreya,Rajesh
Publié: (2024)

Effect Of Core Stabilization Exercises On Lung Function In Post-Menopausal Women
par: Bijoor,Maithili Milind
Publié: (2022)

EFFECT OF PULMONARY EXERCISE ON VITAL LUNG CAPACITY OF AIRLINE CABIN CREW IN INDIA
par: SHIF A SHAFI MOHAMMED KHERADA
Publié: (2019)

DRUG TARGETING TECHNOLOGY
par: SCHREIER HANS
Publié: (2001)

DRUG TARGETING TECHNOLOGY
par: SCHREIER HANS
Publié: (2001)

Correlationbetween Vital Capacity and Six Minute Walk Distance in Patients with Impaired Lung Functions
par: Shaikh Ayesha Mustafa

Gefitinib Nanobubbles for Targetting EGFR-TK in Non -smell Cell Lung Cancer (NSCLC)
par: Drashtri Desai
Publié: (2017)

Cisplatin- Loaded Oxidized Graphene Nanoribbons for Non-Small Cell Lung Carcinoma (NSCLC)
par: Steffi Augustine

Hyaluronic acid modified Erlotinib-Chitosan nanoparticles for Non-small cell lung cancer
par: Chaitali Taiwade

DRUG DISCOVERY AND EVALUATION : PHARMACOLOGICAL ASSAYS 2 VOL.SET
par: VOGEL HANS GERHARD
Publié: (2008)

DRUG TARGETING TECHNOLOGY
par: SCHREIER HANS (ED.)

DRUG TARGETING TECHNOLOGY
par: SCHREIER HANS [E]
Publié: (2001)

PEGYLATED POLYAMIDOAMINE (PAMAM) DENDRIMERS OF GEFTNIB FOR TAGETING EGF-R TYROSINE KINASE IN LUNG CANCER
par: PATIL SAMPADA

Co-delivery of Gefitinib and Paclitaxel as Inhalable Nano Carriers for Non Small Cell Lung Cancer
par: Walvekar Shreya

Effect of incorporating balance training in pulmonary rehabilitation on functional capacity and quality of life in patients with chronic lung diseases
par: Kotecha,Jinaishi Ulhas
Publié: (2024)

DRUG DISCOVERY AND DEVELOPMENT - VOL. 2 : DRUG DEVELOPMENT
par: CHORGHADE MUKUND S. [E]
Publié: (2007)

DRUG STABILITY VOL-107
par: CARSTENSEN JENS T, RHODES
Publié: (2005)

DRUG-DRUG INTERACTIONS
par: RODRIQUES A DAVID
Publié: (2002)

DRUG-DRUG INTERACTIONS
par: RODRIGUES A DAVID [E]
Publié: (2002)

Drug-Drug Interactions
par: David Rodrigues
Publié: (2025)

Drug-Drug Interactions
Publié: (2019)

PRECLINICAL DRUG DEVELOPEMENT VOL-152
par: ROGGE MARK C
Publié: (2005)

DRUG DISCOVERY AND DEVELOPMENT VOL. 1
par: CHORGHADE, MUKUND S
Publié: (2007)

CHIRALITY IN DRUG RESEARCH VOL.33
par: FRANCOTTE ERIC
Publié: (2006)

ORAL DRUG ABSORPTION VOL-106
par: DRESSMAN JENNIFER B
Publié: (2000)

THE DRUG DEVELOPMENT PROCESS VOL.76
par: WELLING PETER G.
Publié: (1996)

CONTROLLED DRUG DELIVERY VOL-20
par: ROBINSON STEPHEN R.
Publié: (2009)

CONTROLLED DRUG DELIVERY VOL.20
par: ROBBINSON JOSEPH R.
Publié: (2007)

TRANSDERMAL DRUG DELIVERY VOL-123
par: GUY RICHARD H
Publié: (2003)

DRUG DESIGN 10 VOL.SET
par: ARIENS E.J
Publié: (2009)

CHEMOINFORMATICS IN DRUG DISCOVERY VOL 23
par: OPREA TUDOR I. [E]
Publié: (2005)

Drug Design Volumes Vol 1
par: Ariens E J
Publié: (2009)